Effect of estrogen status on bone regulating hormones

Bone

Volumn 19, Issue 3, 1996, Pages 227-232

  Zofkova I ^a   Kancheva, Radmila L ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

1,25(OH)2 vitamin D; Calcitonin; Estrogen; Insulin like growth factor I; Oophorectomy; Parathyroid hormone

Indexed keywords

CALCITONIN; CALCITRIOL; CALCIUM ION; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MAGNESIUM; MINERAL; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C;

ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MENOPAUSE; MENSTRUATION; OVARIECTOMY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

EID: 0030247027     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(96)00173-1     Document Type: Article

References (50)

1. 1. Arjmandi, B. H., Hollis, B. W., and Kalu, D. N. In vivo effect of 17β-estradiol on intestinal calcium absorption in rats. Bone Miner 26:181-189; 1994.
2. 2. Bellantoni, M. F., Harman, S. M., Cho, D. E., and Blackman, M. R. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J Clin Endocrinol Metab 72:172-178; 1991.
3. 3. Canalis, E., McCarthy, T. L., and Centrella, M. The role of growth factors in skeletal remodeling. Endocrinol Metab Clin N Am 18:903-918; 1989.
4. 4. Cheema, C., Grant, B. F., and Marcus, R. Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J Clin Invest 83:537-542; 1989.
5. 5. Civitelli, R., Agnusdei, D., Nardi, P., Zacchei, F., Avioli, L. V., and Gennari, C. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 α-hydroxylase reserve in postmenopausal women. Calcif Tissue Int 42:77-86; 1988.
6. 6. Cosman, F., Shen, V., Xie, F., Seibel, M., Ratcliffe, A., and Lindsay, R. Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Ann Intern Med 118:337-343; 1993.
7. 7. Dall'Aglio, E., Valenti, G., Hoffman, A. R., Zuccarelli, A., Passeri, M., and Ceda, G. P. Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis. Horm Metab Res 26:211-212; 1994.
8. 8. Dawson-Hughes, B., Stern, D., Goldman, J., and Reichlin, S. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement. J Clin Endocrinol Metab 63:424-432; 1986.
9. 9. Dick, I. M. and Prince, R. L. Transdermal estrogen replacement does not increase calcitonin secretory reserve in postmenopausal women. Acta Endocrinol 125:241-245; 1991.
10. 10. Dick, I. M., Prince, R. L., Kelly, J. J., and Ho, K. K. Y. Oestrogen effects on calcitriol levels in postmenopausal women: A comparison of oral versus transdermal administration. Clin Endocrinol 43:219-224; 1995.
11. 11. Duursma, S. A., Bijlsma, J. W. J., Van Paassen, H. C., van Buul-Offers, S. C., and Skottner-Lundin, A. Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in postmenopausal women: A pilot study. Acta Endocrinol 106:527-531; 1984.
12. 12. Eriksen, E. F., Colvard. D. S., Berg, N. J., Graham. M. L., Mann, K. G., Spelsberg, T. C., and Riggs, B. E. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-85; 1988.
13. 13. Ernst, M., Heath, J. K., and Rodan, G. A. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology 125:825-833; 1989.
14. 14. Ernst, M. and Rodan, G. A. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 5:1081-1089; 1991.
15. 15. Falch, J. A., Oftebro, H., and Haug, E. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein. J Clin Endocrinol Metab 64:836-841; 1987.
16. 16. Greenberg, C., Kukreja, S. C., Bowser, E. N., Hargis, G. K., Henderson, W. J., and Williams, G. A. Effects of estradiol and progesterone on calcitonin secretion. Endocrinology 118:2594-2598; 1986.
17. 17. Hietala, E.-L. The effect of ovariectomy on periosteal bone formation and bone resorption in adult rats. Bone Miner 20:57-65; 1993.
18. 18. van Hoof, H. J. C., van der Mooren, M. J., Swinkels, L. M. J. W., Rolland, R., and Benraad, Th. J. Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: A 2-year prospective study. Calcif Tissue Int 55:417-419; 1994.
19. 19. Isaia, G. C., Mussetta, M., Massobrio, M., Sciolla, A., Gallo, M., and Molinatti, G. M. Influence of estrogens on calcitonin secretion. J. Endocrinol Invest 15:59-62; 1992.
20. 20. Kalu, D. N., Arjmandi, B. H., Liu, C.-C., Salih, M. A., and Birnbaum, R. S. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner 25:135-148; 1994.
21. 21. Kelly, J. J., Rajkovic, I. A., Osulliven, A. J., Sernia, C., and Ho, K. K. Y. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in postmenopausal women. Clin Endocrinol 39:561-567; 1993.
22. 22. Lazzaretti-Castro, M., Grauer, A., Mekonnen, Y., Raue, F., and Ziegler, R. Effects of 17β-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line. J Bone Miner Res 6:1191-1195; 1991.
23. 23. Leggate, J., Parish, E., Fletcher, C. D., McIntosh, W., Hart, D. M., and Sommerville, J. M. Calcitonin and postmenopausal osteoporosis. Clin Endocrinol 20:85-92; 1984.
24. 24. Linkhart, T. A. and Mohan, S. Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125:1484-1491; 1989.
25. 25. Lo, C. W., Haddock, L., Alpert, M., Serge, G., Slovik, D., Doppelt, S., and Neer, R. Intact serum PTH levels are higher and fail to suppress as readily in postmenopausal women. J Bone Miner Res 3(Suppl 1):157; 1988.
26. 26. Lobo, R. A., Roy, S., Shoupe, D., Endres, D. B., Adams, J. S., Rude, R. K., and Singer, F. R. Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically induced postmenopausal women. Horm Metab Res 17:370-373; 1985.
27. 27. Lund, P. K., Moats-Staats, B. M., Hynes, M. A., Simmons, J. G., Jansen, M., D'Ercole, A. J., and Van Wyk, J. J. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539-14544; 1986.
28. 28. Marcus, R., Villa, M. L., Cheema, M., Cheema, C., Newhall, K., and Holloway, L. Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women. J Clin Endocrinol Metab 74:413-418; 1992.
29. 29. Martínez, M. E., del Campo, M. T., Sánchez-Cabezudo, M. J., Garcia, J. A., Sánchez Calvín, M. T., Torrijos, A., Coya, J., and Munuera, L. Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int 55:253-256: 1994.
30. 30. Mazzuoli, G. F., Tabolli, S., Bigi, F., Valtorta, C., Minisola, S., Diacinti, D., Scarnecchia, L., Bianchi, G., Piolini, M., and Dell'Acqua, S. Effects of salmom calcitonin on the bone loss induced by ovariectomy. Calcif Tissue Int 47:209-214; 1990.
31. 31. Morris, H. A., Porter, S. J., Durbridge, T. C., Moore, R. J., Need, A. G., and Nordin, B. E. C. Effects of oophorectomy on biochemical and bone variables in the rat. Bone Miner 18:133-142; 1992.
32. 32. Oursler. M. J., Osdoby, P., Pyfferoen, J., Riggs, B. L., and Spelsberg, T. C. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88:6613-6617; 1991.
33. 33. Oursler, M. J., Pederson, L., Pyfferoen, J., Osdoby. P., Fitzpatrick, L., and Spelsberg, T. C. Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology 132:1373-1380; 1993.
34. 34. Pérez Cano, R., Montoya, M. J., Moruno, R., Vazquez, A., Galan, F., and Garrido, M. Calcitonin reserve in healthy women and patients with postmenopausal osteoporosis. Calcif Tissue Int 45:203-208; 1989.
35. 35. Pfeilschifter, J., Laukhuf, F., Müller-Beckmann, B., Blum, W. F., Pfister, T., and Ziegler, R. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767-774; 1995.
36. 36. Prince, R. L. Counterpoint: Estrogen effects on calciotropic hormones and calcium homeostasis. Endocrin Rev 15:301-309; 1994.
37. 37. Prince, R. L. Estrogen effects on calciotropic hormones and calcium homeostasis: Update 1995. Endocrin Rev 4:168-169; 1995.
38. 38. Prince, R. L., Dick, I., Garcia-Webb, P., and Retallack, R. W. The effects of the menopause on calcitriol and parathyroid hormone: responses to a low dietary calcium stress test. J Clin Endocrinol Metab 70:1119-1123; 1990.
39. 39. Prince, R. L., Dick, I. M., and Price, R. I. Plasma calcitonin levels are not lower than normal in osteoporotic women. J Clin Endocrinol Metab 68:684-687; 1989.
40. 40. Prince, R. L., Schiff, I., and Neer, R. M. Effects of transdermal estrogen replacement on parathyroid hormone secretion. J Clin Endocrinol Metab 71:1284-1287; 1990.
41. 41. Ravn, P., Overgaard, K., Spencer, E. M. and Christiansen, C. Insulin-like growth factors I and II in healthy women with and without established osteoporosis. Eur J Endocrinol 132:313-319; 1995.
42. 42. Romagnoli, E., Minisola, S., Carnevale, V., Scarda, A., Rosso, R., Scarnecchia, L., Pacitti, M. T., and Mazzuoli, G. Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women. Calcif Tissue Int 53:1-6; 1993.
43. 43. Selby, P. L. and Peacock, M. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women. Clin Endocrinol 25:543-547; 1986.
44. 44. Selby, P. L., Peacock, M., Barkworth, S. A., Brown, W. B., and Taylor, G. A. Early effects of ethinyloestradiol and norethisterone treatment in postmenopausal women on bone resorption and calcium regulating hormones. Clin Sci 69:265-271; 1985.
45. 45. Sims, N. A., Morris, H. A., Moore, R. J., and Durbridge, T. C. Parathyroidectomy does not prevent bone loss in the oophorectomized rat. J Bone Miner Res 9:1859-1863; 1994.
46. 46. Smith, M. L., Fogelman, I., Hart, D. M., Scott, E., Bevan, J., and Leggate, I. Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 44:74-79; 1989.
47. 47. Stock, J. L., Coderre, J, A., and Mallette, L. E. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. J Clin Endocrinol Metab 61:595-600; 1985.
48. 48. Tiegs, R. D., Body, J. J., Wahner, H. W., Barta, J., Riggs, B. L., and Heath, III, H. Calcitonin secretion in postmenopausal osteoporosis. New Engl J Med 312:1097-1100; 1985.
49. 49. Turner, R. T., Backup, P., Sherman, P. J., Hill, E., Evans, G. L., and Spelsberg, T. C. Mechanism of action of estrogen on intramembranous bone formation: Regulation of osteoblast differentiation and activity. Endocrinology 131:883-889; 1992.
50. 50. Weissberger, A. J., Ho, K. K. Y., and Lazarus, L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381; 1991.